328 related articles for article (PubMed ID: 28215507)
1. Significance of uterine corpus tumor invasion in early-stage cervical cancer.
Matsuo K; Machida H; Blake EA; Takiuchi T; Mikami M; Roman LD
Eur J Surg Oncol; 2017 Apr; 43(4):725-734. PubMed ID: 28215507
[TBL] [Abstract][Full Text] [Related]
2. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
[TBL] [Abstract][Full Text] [Related]
3. Post-recurrence survival in patients with cervical cancer.
Cibula D; Dostálek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Scambia G; Ayhan A; Kim SH; Isla Ortiz D; Klat J; Obermair A; Di Martino G; Pareja R; Manchanda R; Kosťun J; Dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benešová K; Borčinová M; Cardenas F; Wallin E; Pedone Anchora L; Akilli H; Abu-Rustum NR; Barquet-Muñoz SA; Javůrková V; Fischerová D; van Lonkhuijzen LRCW
Gynecol Oncol; 2022 Feb; 164(2):362-369. PubMed ID: 34955236
[TBL] [Abstract][Full Text] [Related]
4. The impact of race and partner status on patterns of care and survival in young women with early-stage cervical cancer.
Grover S; Showalter S; Kraft KH; Suneja G; Lin L
Int J Gynecol Cancer; 2013 Mar; 23(3):494-9. PubMed ID: 23388613
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer.
Matsuo K; Machida H; Shoupe D; Melamed A; Muderspach LI; Roman LD; Wright JD
Obstet Gynecol; 2017 Jan; 129(1):139-151. PubMed ID: 27926642
[TBL] [Abstract][Full Text] [Related]
6. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of adenocarcinoma histology in women with cervical cancer.
Galic V; Herzog TJ; Lewin SN; Neugut AI; Burke WM; Lu YS; Hershman DL; Wright JD
Gynecol Oncol; 2012 May; 125(2):287-91. PubMed ID: 22266551
[TBL] [Abstract][Full Text] [Related]
8. Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.
Matsuo K; Huang Y; Matsuzaki S; Ragab OM; Roman LD; Wright JD
Gynecol Oncol; 2021 May; 161(2):414-421. PubMed ID: 33771396
[TBL] [Abstract][Full Text] [Related]
9. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
10. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
[TBL] [Abstract][Full Text] [Related]
11. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer.
Hanprasertpong J; Jiamset I; Geater A; Leetanaporn K; Peerawong T
J Gynecol Oncol; 2017 Jul; 28(4):e42. PubMed ID: 28541633
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
Hanprasertpong J; Jiamset I; Atjimakul T
Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.
Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS
Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 132 cases of cervical adenosquamous carcinoma and cervical adenocarcinoma].
Meng YH; Li S; Hu T; Ma D; Lu YP; Wang H
Chin J Cancer; 2010 Jan; 29(1):15-9. PubMed ID: 20038304
[TBL] [Abstract][Full Text] [Related]
15. Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer.
Matsuo K; Mabuchi S; Okazawa M; Matsumoto Y; Tsutsui T; Fujita M; Kamiura S; Ogawa K; Morrow CP; Kimura T
Br J Cancer; 2013 Apr; 108(6):1348-57. PubMed ID: 23462721
[TBL] [Abstract][Full Text] [Related]
16. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T
Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298
[TBL] [Abstract][Full Text] [Related]
17. Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix.
Matsuo K; Mandelbaum RS; Machida H; Purushotham S; Grubbs BH; Roman LD; Wright JD
J Gynecol Oncol; 2018 Nov; 29(6):e91. PubMed ID: 30207099
[TBL] [Abstract][Full Text] [Related]
18. Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.
Wu SG; Sun JY; He ZY; Chen QH; Zhou J
J Gynecol Oncol; 2017 Nov; 28(6):e81. PubMed ID: 29027399
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
Gemer O; Lavie O; Gdalevich M; Eitan R; Mamanov E; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Meirovitz A; Shachar IB; Arie AB
Am J Clin Oncol; 2016 Feb; 39(1):37-42. PubMed ID: 25734407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
